Department of Epidemiology, New England Research Institutes, Inc., Watertown, MA, USA.
Departments of Medicine and Biostatistics, Boston University, Boston, MA, USA; Department of Psychology and Department of Obstetrics and Gynaecology, University of Western Ontario, London, ON, Canada; Boehringer-Ingelheim Pharma. Inc., Ridgefield, CT, USA.
Erectile dysfunction (ED) is thought to affect some 150 million men worldwide, but many men with ED symptoms do not seek treatment. Existing surveys suggest that men with severe ED and who report support from their partners are more likely to receive treatment than were others. Less is known, however, concerning the influence of sociomedical factors such as income and body composition on receipt of treatment.
The aim of this study was to determine the importance of socioeconomic status, comorbidities, and body composition on receipt of treatment for ED symptoms.
We used data on 638 men enrolled in the Boston Area Community Health (BACH) survey reporting ED symptoms and/or treatment for ED as evidenced by phosphodiesterase type 5 inhibitor (PDE5i) use. Logistic regression was employed to assess the relative strength of association between receipt of treatment and socioeconomic factors, body mass index, and medical factors. A replication of these results was then provided via a parallel model using the 2004 follow-up of the Men's Attitudes to Life Events and Sexuality (MALES).
In BACH, ED was deemed present if a subject scored 16 points or fewer on the five-item International Index of Erectile Function or reported PDE5i use. In MALES, presence of ED was indicated by use of a validated single question querying ED severity.
Controlling for age, body composition and other factors, increased household income, availability of a sexual partner, and provider diagnosis of high blood pressure were positively associated with treatment seeking via the use of PDE5i therapy in BACH. Results on data available in MALES produced similar results for household income and partner availability.
These data provide evidence that financial disadvantage may present a barrier to treatment of ED, an increasingly important sentinel marker of the cardiovascular and overall health among aging men.
Written by:
Travison TG, Hall SA, Fisher WA, Araujo AB, Rosen RC, McKinlay JB, Sand MS. Are you the author?
Reference: J Sex Med. 2011 Aug 11. Epub ahead of print.
doi: 10.1111/j.1743-6109.2011.02423.x
PubMed Abstract
PMID: 21834873
UroToday.com Erectile Dysfunction (ED) Section
